Expression was further enhanced 30-fold (P Ͻ 0.01) with lipoplexes or receptor-targeting and nontargeting polylipofectamine and the ratio of DNA/peptide/lipofectamine plexes. We examined integrin-mediated gene delivery was critical for specificity and expression. Fluorescence using an Arg-Gly-Asp/oligo-L-lysine ([K] 
Introduction
Gene therapy aims to introduce corrective genetic material into cells to relieve the symptoms of disease. A variety of diseases are being considered for application of gene transfer technology, in particular inherited disorders such as cystic fibrosis (for review see Refs 1 and 2). Nonviral systems for delivery of DNA, although less efficient than viral systems, provoke less host inflammatory and immune responses. They consist mainly of cationic liposome-DNA complexes (lipoplexes) or receptortargeting or nontargeting cationic polymer-DNA complexes (polyplexes). Cationic liposomes bind DNA by means of ionic interactions and facilitate DNA delivery by fusion with the plasma membrane, 3 and/or endocytosis. [4] [5] [6] [7] Such vectors are easy to prepare and have limited toxicity, 8 but achieve relatively low transfection levels. Receptor-targeting DNA delivery constructs consist mainly of a receptor-binding ligand, for example transferrin or asialo-orosomucoid, conjugated to a DNA-bind-ing moiety, usually high molecular weight oligo-l-lysine (for review see Refs 9 and 10) .
We have previously demonstrated the principal of integrin-mediated gene delivery using a bifunctional peptide. This molecule is comprised of an integrin receptor-targeting domain containing an arginine-glycine-aspartic acid tripeptide motif and a DNA binding moiety consisting of a stretch of 16 lysine residues, Arg-GlyAsp/oligo-l-lysine ([K] 16 RGD). 11, 12 We showed that this peptide condensed plasmid DNA (approximately 10 nm) rendering it resistant to nuclease degradation and that the level of reporter gene expression obtained in Caco-2 cells under optimal conditions approached that of the commercial liposome lipofectamine. 12 Integrins are a class of related heterodimeric transmembrane surface receptors involved in cell-cell adhesion and in promotion of interactions between cells and components of the extracellular matrix (for review see Ref. 13) . They are able to bind to a wide variety of ligands including extracellular matrix glycoproteins such as fibronectin and vitronectin, while their intracellular domains interact with the cytoskeleton. Integrins are natural targets for receptormediated cell entry used by a variety of pathogenic micro-organisms, including bacteria 14 and viruses. 15, 16 In particular, the adenovirus, a candidate for viral gene therapy, has been shown to require RGD-binding of integrins for internalisation. 17 While both cationic liposome and receptor-mediated molecular conjugates suffer from relatively low transfection efficiencies the association of the two can substantially increase transfection as demonstrated in lung endothelial cells when a poly-l-lysine anti-thrombomodulin antibody conjugate and DNA where associated with a cationic liposome. 18 An additional study also showed enhancement of asialoglycoprotein receptor-mediated DNA transfer into human hepatoma HepG2 cells in the presence of the lipid lipofectam. 19 Hela cells transfected with the ligand transferrin also showed enhanced transfection with the liposome lipofectin. 20 We recently reported first results demonstrating enhancement of integrin-mediated gene delivery by addition of a liposome to melanoma, kidney and endothelial cell lines. 21 In the present report, we extend our study on integrinmediated gene delivery to non-cystic fibrosis and cystic fibrosis human tracheal cells and show that the combination of the [K] 16 RGD peptide with the liposome lipofectamine increases the level of transgene expression about 30-fold (P Ͻ 0.01) above that obtained with the peptide alone. Radioactive and fluorescence labelling studies to examine the cellular delivery of the peptide and DNA components in the presence and absence of lipofectamine demonstrate that lipofectamine improves the efficiency of uptake of the complexes with a certain degree of target specificity by which the RGD motif of the complex binds to integrins on the cell surface of human tracheal epithelial cells. However, lipofectamine also increases nonspecific DNA delivery. Lipofectamine does not seem to have a major influence on endosomal location since confocal microscopy shows rapid accumulation of the complexes in perinuclear vesicles both in its presence and absence.
Results
Competitive inhibition of cell attachment to the integrinbinding domain of fibronectin by an RGD peptide and immuno-detection of the ␤1-integrin subunit The integrin targeting sequence RGDMFG used in our [K] 16 RGD ligand is known to have a high affinity for cellular integrin receptors. Cells normally attach and spread on cell culture wells coated with fibronectin (FN) or vitronectin (VN) through binding of their integrins to the RGD-motif of FN and VN. We demonstrated previously by competitive cell binding studies with the [K] 16 RGD peptide that the RGD domain in our construct maintained its affinity for these integrins after the synthetic fusion with the highly positively charged oligo-llysine chain. 12 These experiments were performed on the Caco-2 intestinal cell line which our group recently showed to express the ␤1-integrin subunit. 22 Since the present study uses tracheal epithelial cells with the longterm aim of correcting the cystic fibrosis defect in airway epithelium, we verified that this cell line also demonstrates binding affinity for the RGD domain of the [K] 16 − cell line and suggests that these cells express integrins which recognise the RGD motif. In addition, we confirmed by fluorescence flow cytometry that the tracheal cell line 56FHTE8o
− expresses the ␤1-integrin subunit. Control cells incubated with the secondary FITC-labelled antibody alone showed a low level of fluorescence while cells incubated with a ␤1-anti-integrin antibody and then the secondary antibody showed increased fluorescence. Similar results for cell attachment and immunodetection were also obtained with another non-cystic fibrosis epithelial tracheal cell line (NT-1) and with two other epithelial tracheal cystic fibrosis cell lines (CFT-1) and (CFT-2) (results are not shown).
Peptide/DNA complex mediated transgene expression enhanced with lipofectamine Oligo-l-lysine binds to DNA and retards its migration during electrophoresis in an agarose gel. 12 By addition of increasing amounts of peptide to a constant amount of plasmid DNA, we found that 0.48 nmol of either the 16 RGD/DNA/liposome-mediated expression is about three orders of magnitude above the value observed with the optimal [K] 16 RGD/DNA ratio without liposome and is about sixfold (P Ͻ 0.01) higher than that of [K] 16 /DNA in the presence of lipofectamine (result not shown). At this liposome ratio (24 g/g DNA) it appears that lipofectamine masks the RGD sequence making it less accessible to cell surface integrins and that transfection is mainly driven by the nonspecific mechanism of liposome-mediated cell entry.
Similar results were also obtained with the other cystic fibrosis and non-cystic fibrosis tracheal cell lines (results not shown).
The obvious next experiment was therefore to try to restore the targeting specificity of the [K] 16 RGD peptide by reducing the lipid to complex ratio. At a ratio of 1:5:18 of DNA/[K] 16 RGD peptide/lipofectamine, we obtained optimal activity whilst retaining about 50% (P Ͻ 0.05) of the targeting specificity ( Figure 2 ). This result suggests that in the presence of lipofectamine, internalisation of the complex is occurring by a mechanism which is independent of integrins.
In conclusion, the [K] 16 RGD peptide not only increases the expression level compared with plasmid DNA by its specific targeting effect, it also enhances the lipofectamine activity nonspecifically as does [K] 16 RGE.
The RGD peptide and lipofectamine increase uptake of 16 
RGD or [K] 16 RGE and lipofectamine was added to semiconfluent tracheal epithelial cells in OptiMEM at the indicated DNA/peptide/lipofectamine ratios. After 4 h the cells were rinsed and a further 48 h later the luciferase activity was determined.
of lipofectamine cell-associated radioactivity at 37°C would include bound and internalised DNA. Because classical endocytosis, an energy-dependent mechanism of cell entry, is blocked at 4°C the cell-associated radioactivity would be limited to cell bound material or radioactive macromolecules that enter by a non-endocytic, possibly fusion, mechanism. Thus the difference between the cell-associated radioactivity at 37°C and 4°C represents uptake by endocytosis.
At 4°C only a constant low level of radioactivity is cellassociated with plasmid alone and plasmid complexed to the [K] 16 In the presence of lipofectamine the amount of cellassociated radioactivity increases rapidly with time and is higher for all combinations at both 4°and 37°C than in the absence of lipofectamine (Figure 3b ). After 3 to 4 h the increase at 4°C is more than 40-fold (P Ͻ 0.02) for the [K] 16 RGD peptide. The relatively high level of cell-asso- ciated radioactivity at 4°C with lipofectamine may suggest either a high degree of binding and/or internalisation of the DNA by a non-energy dependent process. The [K] 16 RGD peptide still shows the highest association. The [K] 16 RGE peptide has a slightly increased association above that of the plasmid but less than the [K] 16 RGD peptide. This was observed both at 4°and 37°C. However, the net uptake (37°-4°C values) with RGD after 4 h is only about 1.6-fold (P Ͻ 0.05) above that of DNA/ lipofectamine and not different from the RGE/DNA/ lipofectamine values. This suggests that under these conditions lipofectamine and not the peptide is responsible for the increase in uptake by endocytosis. The lack of difference in uptake between RGD and RGE (after subtraction of the respective 4°C values) also shows again a loss of peptide mediated specificity in the presence of lipofectamine. This may be partially overcome by use of a lower lipid ratio (Figure 2 ). However, since lipofectamine also increases the amount of cell-associated DNA this nonspecificity may be due in part to DNA internalised by a non-energy-dependent mechanism possibly membrane fusion which is none the less more efficient with [K] 16 RGD. 16 RGD peptide gave gel retardation and luciferase expression results comparable to the unlabelled peptides (data not shown). Semiconfluent cells were incubated with plasmid DNA alone or complexed to peptide, at the optimal DNA to peptide ratio, with or without lipofectamine for the indicated times at 37°C. After incubation for 30 min, the mean fluorescence intensity expressed in arbitrary fluorescence intensity units is 5.0 ± 0.1 for the control, 34. (Figure 5d ) gave yellow which is a result of the combination of the dominant green and red signals which suggested colocalisation of the peptide and horseradish peroxidase. As Cy5 DNA labelling is fainter it did not influence significantly the merged colour. In the presence of the lipofectamine the FITC-peptide (Figure 6a ) and Cy5-DNA (Figure 6b) were also localised to the perinuclear region in large aggregates. Labelling of the nucleus with propidium iodide which binds to nucleic acids confirmed that the peptide complex (Figure 3) . In both, the absence ( Figure 5 ) and presence of lipofectamine ( Figure 6 ) the merged images of the blue and green signals show colocalisation (turquoise) (not shown). The TRITC-horseradish peroxidase (Figure 6c ) with complex containing lipofectamine also appeared to localise to the same region as the peptide and DNA, as confirmed by the merging of the three fluorescence labels (Figure 6d ). Thus confocal microscopy demonstrates internalisation of both the peptide and the DNA in the absence and presence of lipofectamine and localisation to vesicles, prob- 
Discussion
The long-term aim of this work is to develop a vector system that allows delivery of DNA sequences coding for the normal cystic fibrosis transmembrane conductance regulator gene, the gene which is defective in cystic fibrosis, to the airways in a cell-specific manner allowing high expression for gene therapy in vivo. We noted recently that the combination of these two types of nonviral vectors, a cationic lipid lipofectamine and an integrin-binding poly-l-lysine conjugate increased substantially the expression level in human tracheal epithelial cells. Maximal expression was dependent on the amount of complex and on the ratio of DNA-topeptide-to-lipofectamine.
An increase in delivery and expression in endothelial cells was observed when a poly-l-lysine antibody conjugate and DNA were associated with a cationic liposome. 18 Another study reported enhancement of asialoglycoprotein receptor-mediated DNA transfer into human hepatoma HepG2 cells in the presence of the lipid lipofectam. 19 Enhanced transferrin-mediated gene transfer in the presence of the cationic lipid lipofectin in Hela cells has been reported. 20 Using [
35 S]-labelled plasmid DNA the authors also showed enhanced intracellular DNA transfer by transferrin in the presence of lipofectin.
The enhanced effect may be due to increased uptake of DNA, but also to protection of the DNA by the liposomes in the extracellular medium allowing the complex to interact with the cell surface. We found that both lipofectamine and peptide protects the plasmid DNA from degradation by DNase (not shown). Liposomes may also protect the DNA by delaying its passage to lysosomes as suggested by a study which examined the subcellular distribution of [ 35 S]-labelled DNA in rat liver. 23 Delayed degradation may mean that there is a greater chance that the DNA passages to the nucleus.
The specificity of the integrin binding was demonstrated by an increase in luciferase activity with the [K] 16 RGD peptide over the [K] 16 RGE peptide in the absence of lipofectamine. However, this specificity was lost in the presence of high ratios of lipofectamine and was only partially restored at lower ratios. This suggests that the amount of lipid may modify the interaction of the [K] 16 RGD peptide with the cell surface integrins which we demonstrated by two independent methods to be present on human epithelial tracheal cells. In fact the binding affinity of vitronectin (VN) for its integrin receptor has been shown to be modulated by the amount and composition of liposomes. 24 In addition, these results suggest that the complex is entering by a mechanism that is not receptor-mediated. We also noted that the 16 enter the cell to a significant level, thus a nuclear targeting effect is absent and the two show the same expression level. These questions are being further investigated.
We also showed that lipofectamine increases the level of cell-associated conjugate and DNA. This cell association represented predominantly endocytosed peptide RGD conjugate and DNA, as demonstrated by confocal microscopy, and suggested that lipofectamine facilitates intracellular delivery of complex. The high percentage of cells labelled with complex containing lipofectamine as detected with fluorescence flow cytometry suggests that cell entry in this system is not a limiting step to DNA delivery. In addition, the confocal results showed cointernalisation of the peptide and DNA and localisation in vesicles in the perinuclear region in both the presence and absence of lipofectamine. RGD is a common motif found in many extracellular matrix proteins that bind to integrins including FN and VN. Internalisation of VN by means of the endosome-lysosome pathway has been shown to be dependent on integrins 25 and to be inhibited by RGD peptides. 26 Although endocytosis appears to be the major entry route, as indicated by previous studies, [4] [5] [6] [7] this does not exclude the possibility that some of the uptake with lipofectamine is driven by an energy-independent process, probably membrane fusion, as suggested by the cell association of labelled DNA at 4°C and as proposed previously. 3 Further studies into the endocytic mechanisms and intracellular trafficking of the vector are proceeding.
Integrins are a family of ubiquitous proteins which have been shown to be present on the airways although the FN and VN-binding integrins are either not or only expressed at low levels in normal lung epithelia. 27, 28 However, their expression is increased during the wound repair process in airway epithelia and in the injured airways of cystic fibrosis patients.
28, 29 Moreover, recombinant adenovirus-mediated gene transfer which is RGD dependent occurs preferentially in areas of injured epithelium. 28 Thus the injured airway observed in cystic fibrosis may be susceptible to gene transfer with an integrin-mediated delivery system. In addition, cationic liposomes have been shown not to provoke adverse events in cystic fibrosis patients and to bring about a level of gene transfer comparable to that reported for adenoviral vectors. 8 The results to date indicate that cationic liposomes coupled with integrin-mediated gene delivery enhance the transfection efficiency of the RGD vector probably by improving the efficiency of uptake of the complexes through a receptor-mediated mechanism and through protection of the DNA by lipofectamine and the peptide. This nonviral vector system is a first step towards development of cell-specific targeting of the airway for gene therapy of cystic fibrosis. 12 Peptides were purified by HPLC on a C18 preparative column and characterised by matrix-assisted laser desorption/ionisationtime of flight (MALDI-TOF) mass spectrometry and amino acid sequencing, as described previously. 12 The purity of each peptide was in excess of 95%. Fluorescein isothiocyanate (FITC)-labelled versions of [K] 16 RGD and [K] 16 RGE peptides were prepared by coupling FITC isomer I to solid phase resin-bound samples of both peptides. Labelled peptides were separated from unlabelled peptides, after release from the resin, by HPLC as described above. All peptides were cyclised before use by oxidation in HEPES buffered saline (HBS, 150 mm NaCl, 10 mm Hepes, pH 7.3) and the formation of disulphide bonds monitored as previously described. 12 The oligo-llysine [K] 16 peptide was synthesised by Genosys Biotechnologies (Cambridge, UK) and purified by HPLC on a VYDAC RP C-8 column to 98% purity.
Materials and methods

Cell culture
A foetal human tracheal epithelial cell line 56FHTE8o − obtained from a non-cystic fibrosis foetus was kindly provided by D Gruenert. 30 Another non-cystic fibrosis human foetal tracheal cell line (NT-1) and two cystic fibrosis foetal tracheal cell lines CFT-1 and CFT-2 were prepared and established in the same way in our laboratory. 31, 32 Cells were grown in a 1:1 mixture of Dulbecco's minimum essential medium (DMEM) and Ham's F-12 nutrient medium (DMEM/F-12) containing 50 U/ml penicillin and 50 U/ml streptomycin (ATGC, Noisy le Grand, France) and supplemented with foetal calf serum (10% v/v) (Boehringer Mannheim, Meylan, France). Caco-2 cells were kindly provided by Dr A Zweibaum of INSERM U178, France and cultured in DMEM (4.5 g/l glucose) supplemented with 10% foetal calf serum, 2 mm l-glutamine and non-essential amino acids. Cells were maintained at 37°C in 5% CO 2 95% air and the medium changed every second day.
Cell attachment and inhibition
The wells of non-tissue culture 96-well plates (TPP, Trafadingen, Switzerland) were coated either with fibronectin (FN), vitronectin (VN) (Sigma, Saint Quantin Fallavier, France) both from human plasma (0.1 mg/ml in PBS) or bovine serum albumin (BSA) 3% overnight at room temperature. The wells were then rinsed twice with PBS and blocked with 3% BSA/PBS for 1 h at 37°C. Cells from 75-cm 2 flasks were harvested in EDTA (2 mm) in PBS and centrifuged at 500 g for 10 min. The cell suspension was diluted in DMEM/F-12 to 1 × 10 6 cells and 
DNA preparation and labelling
An American firefly (Phoptinus pyralis) luciferase DNA plasmid (5256 bp) under the control of an SV40 promoter and enhancer (Promega, Charbonnieres, France) was used as a reporter gene. Plasmid DNA was purified using Qiagen columns and the endotoxin-free Maxi kit after alkaline lysis of cells pelleted from overnight cultures of Escherichia coli DH5␣.
The plasmid was labelled by a modified nick-translation technique, which uses either no or very low levels of DNase and thereby preserves intact the plasmid DNA as previously described. 34 The DNA was labelled with were mixed with the plasmid DNA pGL3 at a ratio of 5:1 (w:w), respectively and incubated for 15 min at room temperature in HEPES buffered saline. Peptide at this ratio condenses the DNA as shown by electron microscopy and renders it resistant to DNase. 12 Lipofectamine (Gibco BRL) (2 mg/ml) a 3:1 (w:w) mixture of a polycationic lipid (DOSPA) and a neutral lipid (DOPE) was then added (final ratio DNA/peptide/lipofectamine; 1:5:24 (w:w:w) unless otherwise indicated) and the mixture incubated a further 15 min. DNA retardation was determined as previously described.
12
Luciferase assay Cells were seeded on 12-well cell culture plates at a density of 4 × 10 5 cells per well and incubated at 37°C for about 12 h until 50% confluency. The components of the vector complex (DNA/peptide/Lipofectamine, 0.08 g:0.4 g:1.9 g, per well) alone or together were added to the cells in a final volume of 200 l of Opti-MEM. Cells were then incubated at 37°C for 4 h after which the components of the complex were removed. The cells were then washed in PBS, the normal supplemented media added and incubated for a further 48 h after the transfection period. Forty-eight hours was found to give optimal activity. Luciferase activity was assayed after washing cells twice with 1 ml of PBS and harvesting in 400 l of lysis buffer (25 mm Tris/H 3 PO 4 , pH 7.8, 1% Triton X-100, 15% glycerol, 1 mm EDTA, 10 mm MgCl 2 , 1 mm DTT) for 15 min at 4°C. The cell lysate was then transferred to 1.5 ml Eppendorf tubes and centrifuged for 10 min at 21 700 g to pellet cellular debris. Luciferase activity of cell lysate was then determined on an aliquot (100 l) using a Berthold (Evry, France) luminometer (Lumat LB9507) with a 60 s integration period after automatic injection of 100 l of a d-luciferin solution (lysis buffer without DTT, with 100 mm ATP, 43 mg/ml dluciferin). The protein concentration of cell lysates was determined using the Bradford method. 16 RGE complex (0.02 g DNA per well) with or without lipofectamine for different times at 37°C. The cells were rinsed with PBS, harvested with 250 l trypsin/EDTA per well for 10 min at 37°C or for 1 h at 4°C before being blocked with 250 l of 1% BSA in PBS and recovered by centrifugation. The cell pellet (10 min, 100 g) was rinsed once in PBS by centrifugation before lysis in 1 n NaOH. The protein concentration was determined by the method of Bradford 33 and the radioactivity measured by scintillation counting with Ecolite (ICN, Orsay, France) in an LKB Rackbeta 1209 counter.
Fluorescence flow cytometry
Fluorescence flow cytometric analysis was performed on a Cytofluorograph IIs (Ortho Diagnostic Systems, Westwood, MA, USA). For ␤1 integrin immunodetection cells were detached with 5 mm EDTA in PBS, counted and rinsed three times with 3% BSA in PBS. 5 × 10 5 cells were then incubated with a mouse monoclonal anti-human CD29 (␤1 integrin) antibody (0.1 mg/ml, Cliniscience, Birmingham, AL, USA) at a 1/50 dilution for 30 min at 4°C. Cells were then washed three times with 3% BSA in PBS and then incubated with a fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (2 mg/ml; Biosys, Compiegne, France) at a 1/20 dilution for 30 min at 4°C. After three rinses the cells were resuspended in DMEM without phenol red and analysed. Negative controls consisted of cells incubated with only the anti-IgG antibody. Confocal laser scanning microscopy Cells (1.5 × 10 4 cells per well) were plated on Labtek 8-well plates (Gibco BRL) and the following day fluorescein-labelled [K] 16 RGD/Cy5-labelled DNA complex, at the above indicated optimal ratio, (0.3 g DNA per well) was added together with or without lipofectamine in OptiMEM for 30 min; the same batch of labelled DNA and peptide were used. Tetramethylrhodamine-5-isothiocyanate (TRITC) labelled horseradish peroxidase (150 g/ml; Sigma), a fluid phase marker which enters intracellular vesicles was then added to the cells rinsed twice in PBS and incubated for 5 min in PBS containing 5% BSA. The cells were washed twice in PBS and the fluorescence was examined with a Leica TCS microscope equipped with a DMR inverted microscope and a 63/1.4 objective. A krypton-argon mixed-gas laser was used to generate three bands: 488 nm for FITC, 568 nm for TRITC and 657 nm for Cy5. A band pass filter was used to recover FITC fluorescence, a LP 590 filter was used for TRITC and a LP 650 filter was used for Cy5. Images were processed using a Power Mac 7500/100 equipped with Photoshop and printed on a Kodak XLS 8600 P.S. printer.
Statistical analysis
The results are representative of three experiments where each point was performed in triplicate and presented as the mean ± s.e.m. Statistical analysis was performed using the nonparametric rank test of Wilcoxon. Probability values Ͻ0.05 were considered statistically significant.
